Format

Send to

Choose Destination
J Dermatolog Treat. 2003 Dec;14(4):229-32.

Etanercept therapy in patients with autoimmunity and hepatitis C.

Author information

1
Department of Medicine and Clinical Research Center, UMDNJ-Robert Wood Johnson Medical School, 51 French Street, New Brunswick, NJ 08901-0019, USA.

Abstract

Accumulated data suggest that etanercept may be a therapeutic option in patients with hepatitis C and coexisting autoimmune disorders such as rheumatoid arthritis, psoriasis, psoriatic arthritis and ankylosing spondylitis. Additionally, etanercept may actually be of benefit, when used in combination with standard treatments, for hepatitis C.

PMID:
14660270
DOI:
10.1080/09546630310020470
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center